Mangieri George J 4
4 · WESTLAKE CHEMICAL CORP · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Mangieri George J
VP & Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2018-02-28$61.87/sh+1,489$92,117→ 5,810 total - Exercise/Conversion
Common Stock
2018-02-28$68.09/sh+1,036$70,541→ 8,656 total - Exercise/Conversion
Employee Option (right to buy)
2018-02-28−1,489→ 3,026 totalExercise: $61.87Exp: 2027-02-17→ Common Stock (1,489 underlying) - Exercise/Conversion
Common Stock
2018-02-28$44.42/sh+1,810$80,400→ 7,620 total - Sale
Common Stock
2018-02-28$111.22/sh−4,335$482,139→ 4,321 total - Exercise/Conversion
Employee Option (right to buy)
2018-02-28−1,810→ 1,865 totalExercise: $44.42Exp: 2026-02-18→ Common Stock (1,810 underlying) - Exercise/Conversion
Employee Option (right to buy)
2018-02-28−1,036→ 0 totalExercise: $68.09Exp: 2025-02-20→ Common Stock (1,036 underlying)
Footnotes (4)
- [F1]The stock options are excercisable in three installments of 33%, 33% and 34% on February 17, 2018, 2019 and 2020, respectively.
- [F2]The stock options are excercisable in three installments of 33%, 33% and 34% on February 18, 2017, 2018 and 2019, respectively.
- [F3]The stock options are excercisable in three installments of 33%, 33% and 34% on February 20, 2016, 2017 and 2018, respectively.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $111.2128 to $111.265, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.